Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stussi, Gisela Müller, Nathan Cantoni, Richard Cathomas, Ulrich Mey, Anouk Widmer, Thorsten Zenz, Michael Gregor, Dominik Heim, Martin Andres, Rudolf Benz, Davide Rossi. "Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial." Blood, 2025. doi:10.1182/blood.2024026879